| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.09 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |